ASX:MVFMonash IVF Group Stock Price, Forecast & News

A$0.57

0.00 (0.00 %)

(As of 05/12/2020)

Add

Compare

Today's Range

A$0.57

Now: A$0.57▼

A$0.60

50-Day Range

A$0.54

MA: A$0.61▼

A$0.83

52-Week Range

A$0.38

Now: A$0.57▼

A$1.54

Volume9.00 million shs

Average Volume729,133 shs

Market Capitalization$222.09 million

P/E Ratio6.79

Dividend Yield8.07%

BetaN/A

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. It provides fertility research and treatment services, tertiary level prenatal diagnostic services, low intervention IVF services, and diagnostic ultrasound services. The company operates 22 fertility clinics, 18 specialist women's imaging sites, 5 service centers, 2 specialized diagnostic laboratories, and 3 day hospitals. The company was incorporated in 2014 and is based in Richmond, Australia.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Monash IVF Group.

2.3 Community Rank

Outperform Votes
Monash IVF Group has received 67 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Monash IVF Group has received 78 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Monash IVF Group has received 53.79% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Monash IVF Group and other stocks. Vote “Outperform” if you believe MVF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MVF will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Leadership
Monash IVF Group is a leading dividend payer. It pays a dividend yield of 8.07%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Monash IVF Group does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Monash IVF Group is 59.52 %. This payout ratio is at a healthy, sustainable level, below 75%.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Monash IVF Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$10,069.00 in company stock and sold A$0.00 in company stock.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Monash IVF Group are expected to decrease by -100.00% in the coming year, from A$0.13 to A$0.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Monash IVF Group is 6.79, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.84.
Price to Earnings Ratio vs. Sector
The P/E ratio of Monash IVF Group is 6.79, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.88.
Price to Book Value per Share Ratio
Monash IVF Group has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.94 out of 5 stars

Industry, Sector and Symbol

Stock Exchange ASX

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolASX:MVF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.monashivfgroup.com.au

Phone+61-3-94208235

Debt

Debt-to-Equity Ratio51.58

Current Ratio0.64

Quick Ratio0.38

Price-To-Earnings

Trailing P/E Ratio6.79

Forward P/E Ratio4.26

P/E GrowthN/A

Sales & Book Value

Annual Sales$151.98 million

Price / Sales1.46

Cash FlowA$0.02 per share

Price / Cash Flow31.67

Book ValueA$0.74 per share

Price / Book0.78

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees588

Outstanding Shares389,635,008

Market Cap$222.09 million

Next Earnings DateN/A

OptionableNot Optionable

Receive MVF News and Ratings via Email

Sign-up to receive the latest news and ratings for MVF and its competitors with MarketBeat's FREE daily newsletter.

Monash IVF Group (ASX:MVF) Frequently Asked Questions

How has Monash IVF Group's stock been impacted by COVID-19 (Coronavirus)?

Monash IVF Group's stock was trading at A$0.81 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MVF shares have decreased by 29.6% and is now trading at A$0.57. View which stocks have been most impacted by Coronavirus.

How were Monash IVF Group's earnings last quarter?

Monash IVF Group Ltd (ASX:MVF) issued its earnings results on Monday, August, 27th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.10 by $0.01. View Monash IVF Group's earnings history.

How often does Monash IVF Group pay dividends? What is the dividend yield for Monash IVF Group?

Monash IVF Group declared a Interim dividend on Monday, February 24th. Shareholders of record on Friday, April 3rd will be paid a dividend of 0.021 per share on Friday, April 3rd. This represents a dividend yield of 2.09%. The ex-dividend date is Thursday, March 5th. View Monash IVF Group's dividend history.

Has Monash IVF Group been receiving favorable news coverage?

Media stories about MVF stock have trended positive on Saturday, according to InfoTrie. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Monash IVF Group earned a media sentiment score of 2.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutMonash IVF Group.

Who are some of Monash IVF Group's key competitors?

Some companies that are related to Monash IVF Group include Cel-Sci (CVM), SIGA Technologies (SIGA), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Neptune Wellness Solutions (NEPT), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL), ProMetic Life Sciences (PLI), Medicenna Therapeutics (MDNA), IMV (IMV), Exicure (XCUR), Emblem (EMC), Pfenex (PFNX) and Fennec Pharmaceuticals (FRX). View all competitors.

What other stocks do shareholders of Monash IVF Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Monash IVF Group investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Surgery Partners (SGRY), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS) and Aquantia (AQ).

Who are Monash IVF Group's key executives?

Monash IVF Group's management team includes the following people:

Mr. Michael D. Knaap, Interim CEO & Company Sec.
Mr. Brett Comer, Chief Operations Officer
Dr. Richard Charles Henshaw, Exec. Director
Mr. Malik Jainudeen, CFO & Company Sec.
Mr. Pierre Abou Haila, Chief Information Officer

What is Monash IVF Group's stock symbol?

Monash IVF Group trades on the ASX under the ticker symbol "MVF."

What is Monash IVF Group's stock price today?

One share of MVF stock can currently be purchased for approximately A$0.57.

How big of a company is Monash IVF Group?

Monash IVF Group has a market capitalization of $222.09 million and generates $151.98 million in revenue each year. Monash IVF Group employs 588 workers across the globe.

What is Monash IVF Group's official website?

The official website for Monash IVF Group is www.monashivfgroup.com.au.

How can I contact Monash IVF Group?

Monash IVF Group's mailing address is Pelaco Bldg, 1/21-31 Goodwood St, RICHMOND, VIC 3121, Australia. The company can be reached via phone at +61-3-94208235.

This page was last updated on 6/6/2020 by MarketBeat.com Staff